So this is published, it's the journal of antioxidant
While this protocol proved instrumental in the elucidation of fundamental redox reactions of GSH, its application is limited by the low stability of DMPO/ SG (t 1/2 50 s) 28,29,30,31
The numbers were clear
See our Mounjaro vs Ozempic guide
The weight loss mechanism differs as well: GLP-1 agonists work through delayed gastric emptying and central appetite suppression, while berberine's weight effects, when present, likely relate to improved insulin sensitivity and metabolic efficiency
These are brand-stated, mechanism-level descriptions, not this publication's independent clinical claims, and they're broadly consistent with how GLP-1 and GIP receptor agonists are discussed in general medical literature